The potential of targeting microRNA-23b-3p signaling in Alzheimer's disease: opinions on recent findings

Front Pharmacol. 2023 Jul 12:14:1245352. doi: 10.3389/fphar.2023.1245352. eCollection 2023.
No abstract available

Keywords: Alzheimer’s disease; glycogen synthase kinase-3β; microRNA therapy; microRNA-23b-3p; tau protein.

Grants and funding

The paper was supported by the National Natural Science Foundation of China (No. 82173806).